Home/Filings/4/A/0001209191-23-017762
4/A//SEC Filing

Wisel Camela 4/A

Accession 0001209191-23-017762

CIK 0001627223other

Filed

Mar 9, 7:00 PM ET

Accepted

Mar 10, 1:53 PM ET

Size

5.9 KB

Accession

0001209191-23-017762

Insider Transaction Report

Form 4/AAmended
Period: 2023-03-01
Wisel Camela
VP, CAO & Controller
Transactions
  • Award

    Performance Stock Option (Right to Buy)

    2023-03-01+5,0105,010 total
    Exercise: $38.32Exp: 2033-03-01Common Stock (5,010 underlying)
Footnotes (3)
  • [F1]Represents a 10 percent premium above the closing price of the Company common stock on the date of grant
  • [F2]The original Form 4, filed on March 3, 2023, is amended by this Form 4 amendment solely to revise the number of performance stock options received by the reporting person.
  • [F3]These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.

Issuer

Chemours Co

CIK 0001627223

Entity typeother

Related Parties

1
  • filerCIK 0001886003

Filing Metadata

Form type
4/A
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 1:53 PM ET
Size
5.9 KB